2025. Efficacy of Risankizumab on Symptoms in Patients With Scalp Psoriasis in a Post-Hoc Analysis of the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16. SKIN The Journal of Cutaneous Medicine. 9, 6 (Nov. 2025), s636. DOI:https://doi.org/10.25251/57ey8s02.